T-cell hybridomas are highly metastatic, and their in vitro invasiveness correlates with metastatic capacity. Invasion is blocked by pertussis toxin (W), which adenosine diphosphate (ADPI-ribosylates GI-proteins, and we have provided evidence that the PT-sensitive signal stimulates leukocyte function-associated antigen-l (LFA-l)-mediated adhesion required for invasion. PT pretreatment of TAM2D2 T-cell hybridoma cells reduced metastasis, but only to a limited extent. In the present study, we have transfected the cDNA of the PT ADP-ribosyltransferase S1 subunit into TAM2D2 cells to abrogate Gl-protein function permanently. We report here a substantial reduction in the metastatic capacity of two C IRCULATING BLOOD cells express integrins, but bind poorly or not at all to their ligands. Adhesion requires activation of the cells, eg, by factors such as C5a, FMLP, interleukin-8 (IL-8), or platelet-activating factor (PAF), produced at sites of inflammation, which thus regulate influx of cells into these sites.'.' Activation by these factors is often inhibited by pertussis toxin (FT), which adenosine diphosphate (ADP)-ribosylates Gi-proteins; thus, adhesion apparently requires signals transmitted by G,-proteins.' PT causes lymphocytosis, indicating that, in noninflamed tissues, migration of lymphocytes requires similar signals, as has in fact been shown for migration through high endothelial venules of the lymph node' and out of the thy mu^.^ Metastasis formation by hematopoietic tumor cells starts with the invasion of blood-borne tumor cells into tissues. We have shown that metastatic lymphoma cells and activated normal T cells invade hepatocyte cultures, a model for in vivo invasion of the This suggested that invasion mechanisms of normal and transformed blood cells are similar. Indeed, T-cell hybridomas generated by fusion of activated T cells with the nonmetastatic T lymphoma BW5147 were highly metastatic, particularly to the liver, but also to many other organ^.^ We regard the T-cell hybridomas, therefore, as a model for both migration of normal activated T cells into noninflamed tissues and for metastasis formation by lymphoid tumors.
metastasis in vivo.' Yet, the cells do not adhere to intercellular adhesion molecule-l (ICAM-l), indicating that LFA-1 is not in the active state. FT treatment of TAM2D2 cells reduced invasion and metastasis.'" The divalent cation Mn2' induced adhesion of the cells to the LFA-1 ligand ICAM-1, and we observed that PT-pretreated cells, which were virtually noninvasive, invaded extensively in the presence of Mn"." Also, phorbol myristate acetate (PMA) stimulated LFA-1 -mediated adhesion and reversed the inhibition of invasion by PT (La Rivibre et al, unpublished results). We propose therefore that PT blocks a signal delivered by an extracellular factor that is required for activation of LFAl-mediated adhesion and, hence, for invasion.'' This also implies that metastasis in vivo is dependent on factors present in the metastatic target organs such as the liver, ie, in noninflamed tissues, To investigate this, we have previously assessed metastasis formation of TAM2D2 T-cell hybridoma cells after PT-pretreatment." The results supported a role of G-protein signals in metastasis. However, the effect was limited, ie, reduction of the tumor burden in the liver to 10% to 25% of controls and no clear effect on metastasis to other sites such as spleen, kidneys, and ovaries. Therefore, either the role of G-proteins in metastasis is marginal or the limited effect was due to the restricted duration of the toxin effect. To distinguish between these two possibilities, the present study was performed.
PT catalyzes the ADP-ribosylation of Gi-proteins, causing their uncoupling from the receptor and hence a blockade of signals transmitted on binding of receptor agonists." PT consists of five subunits, but only the S1 subunit is required for ADP-ribosylation. The others mediate binding to and translocation across the plasma membrane." G-proteins are heterotrimers that are associated with membranes and are involved in multiple signal pathway^.'^." The guanosine diphosphate (GDP)-bound trimer binds to cell surface receptors, in most cases proteins with seven transmembrane domains. Interaction of agonists with these receptors triggers a change in G-protein conformation, resulting in GDP-GTP exchange and dissociation of the a-subunit from the hsubunits. GOI and fly-subunits activate effectors such as adenylyl cyclase, phospholipases, ion channels, tyrosine and serine-threonine kinases." The PT-sensitive G-proteins expressed by T lymphocytes are Ga,* and G O I ,~. '~ Chaffin et all7 generated transgenic mice, in which the S1 catalytic For personal use only. on October 27, 2017. by guest www.bloodjournal.org From 3117 subunit was expressed under the control of a thymus-specific promoter. They found that thymocytes developed normally, but that the mature T cells did not leave the thymus" and, on transfer to other mice, were unable to leave the blood: This provided compelling evidence that FT-sensitive G-proteins are essential for T-lymphocyte migration.
G,-PROTEINS INVOLVED IN T-CELL HYBRIDOMA METASTASIS
We have used here a similar approach to investigate the role of PT-sensitive G-proteins in metastasis. We transfected the cDNA of the S1 ADP-ribosyltransferase subunit of PT into TAM2D2 T-cell hybridoma cells to inhibit Gi-protein signaling permanently. We found that metastasis by a S1 transfectant, in which 95% of the Gi-proteins was ADPribosylated, was strongly reduced, especially in the liver, but also in other organs. For a second transfectant, with 88% ADP-ribosylated G, -proteins, less metastases were also formed in the liver and the spleen. We conclude that G,-protein-mediated signals are essential for metastasis formation by T-cell hybridomas.
MATERIALS AND METHODS
Cells and culture conditions. The highly invasive T-cell hybridoma TAM2D2 and S1 transfectants were cultured in hybridoma medium as described.'8 Rat embryo fibroblast 208F (REF) cells were cultured in Dulbecco's modified Eagle's medium (DME) with 10% newborn calf serum (GIBCO BRL, Paisley, UK) and used for invasion assays between passages 5 and 15.
Generation of S I cDNA expression construct. S1 cDNA was removed from vector ~1 0 1 7 '~ by BamHI digestion. The BamHI site is located just 3' of the initiation codon. To regenerate the initiation codon, the recessed termini were filled in and blunt ligated to the MFG-lacZ retroviral vector," which had been digested with NCO I and BamHI and also filled in. Subsequently, the resulting MFG-S1 construct was digested with Nhe I and Xba I and the 1.0-kb S1 cDNA fragment was cloned into the Xba I site of the expression vector pcDNAhyg, directing expression of the S1 cDNA from the cytomegalovirus (CMV) promoter. pcDNAhyg was made by cloning the hygromycin resistance gene under the control of the pgk promoter as a blunt Bgl I1 fragment" into the Sca I site of pcDNA I (Invitrogen, San Diego, CA). The presence of the correct translation initiation sequence was confirmed by DNA sequencing.
Generation of S1 transfectants. TAM2D2 cells (2 X lo7) in 0.8 mL RPM1 medium were electroporated in the presence of 100 pg pcDNASlhyg or pcDNAhyg plasmid (both linearized with Nhe I) using the Bio-Rad gene pulser (360 V, 960 pF; Bio-Rad, Richmond, CA). Cells were seeded in 48-well culture dishes at 5 X IO4 and IO4 cells per well in hybridoma medium with 20% fetal calf serum (FCS). Drug selection (1.5 mglmL hygromycin B; Calbiochem, La Jolla, CA) was started after 1 day.
Northern hybridization. RNA was isolated with the Ultraspec kit according to the manufacturer's protocol (Biotecx, Houston, TX). Twenty micrograms was loaded on a 1.0% agarose formaldehyde gel. After electrophoresis, material was transferred to Nytran 13N membrane (Schleicher and Schuell, Damsel, Germany) and hybridized using standard techniques.
Defection of S2 protein. Cells were homogenized at 4°C in a Teflon glass homogenizer in 20 mmolL Tris-HC1, pH 7.5, 1 mmoll L EDTA, 1 mmoUL dithiothreitol (DTT) supplemented with 20 pgl mL soybean trypsin inhibitor (Sigma, St Louis, MO), 2 pg/mL aprotinin (Bayer, Leverkusen, Germany), and 0.5 mmolL pefabloc (Boehringer Mannheim, Indianapolis, IN). Cell lysate was collected after spinning down the nuclei for 10 minutes at 200g. Protein concentration was determined by BCA protein assay (Pierce, Rockford, IL). Ten micrograms of protein was separated by 12% sodium &de-cy1 sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transferred to nitrocellulose, and immunoblotted in IO mmoVL Tris-HC1, pH 8.0, 150 m m o K NaCl, 0.2% Tween-20 supplemented with 1% bovine serum albumin (BSA), and 3% nonfat dried milk. Ascites of murine monoclonal antibody (MoAb) 151C1 against PT S1 subunit (a gift from Dr J. Poolman; Netherlands Institute of Health, Bilthoven, The Netherlands) was used at a dilution of 1:5,000 and the secondary reagent sheep antimouse IgG was conjugated to peroxidase (Amersham, Arlington Heights, IL) at a dilution of 1:10,000. Bound antibodies were detected using enhanced chemiluminescence (ECL) detection (Amersham).
ADP-ribosylation assay. Cells were homogenized as described above. After centrifugation for 10 minutes at 200g, membranes were collected by centrifugation for 30 minutes at 160,OOOg and suspended in 20 mmoVL Tris-HC1, pH 7.5, 1 mmol/L EDTA, 1 mmoU L DlT. Protein concentration was determined by BCA protein assay (Pierce). F T substrates in transfectants were assayed using a modification of the procedure described by Chaffin et aLi7 Twenty micrograms of membrane protein was used per reaction. To test whether ADP-ribosylating activity was present in the lysate, 10 pg lysate was incubated with 20 pg TAM2D2 membrane protein. IT and subjected to SDS-PAGE in a 10% gel. After electrophoresis, gels were stained with Coomassie blue, destained, dried, and exposed to Kodak X-AR film (Eastman Kodak, Rochester, NY) overnight. Quantitation of the incorporation of 32P-ADP was performed by phosphoimaging analysis (Fujix; BAS2000).
Western blot of G-protein a and p subunits. Membranes were prepared as described for the ADP-ribosylation assay. Fifteen micrograms of membrane proteins was resolved on 10% SDS-polyacrylamide gels, transferred to polyvinylidene fluoride (PVDF) membranes, and immunoblotted using the following affinity-purified antisera: AS 7, selective for a,, and a,*; EC, selective for ai3; and QL, selective for a4 and a , I . To study p subunit expression, we used antiserum SW directed against the carboxy-terminal sequence GSWDSKKIWN of the p subunit. All sera were kindly provided by Dr S. Hermouet and are described in a previously published study" and references therein. Antibody-antigen complexes were detected by ECL (Amersham). I mmol/L MgClz into a tail vein of syngcncic 2-to 3-month-old AKK mice. Animals were autopsied when moribund or after the indicated time and examined for metastases both macroscopically and microscopically. Their livers and spleens were weighed. Statistical analysis was performed with logarithms o f liver and spleen weights in the Student's t-test.
Adhesion of cells to soluble intercellular adhesion molecule-I (sZCAM-I).

RESULTS
SI trmsfectants of TAM2D2 cells express SI mRNA.
TAM2D2 T-cell hybridoma cells were transfected with the pcDNAhygSI expression vector or the negative control pcDNAhyg. Invasion of transfectants into REF monolayers was determined. Of 60 transfectants, 6 that in an initial screening test appeared to be low-invasive were selected for further analysis, together with 6 others. The cells were screened for SI expression by Western blotting, but expression was not detected. Northern blot analysis showed that 2 of the 12 transfectants, S05 and S09. expressed a high level of S 1 mRNA (Fig I ) Table 1 , the incorporation of label into the Gcq-subunits is shown and compared with the parental TAM2D2 cells. In the TAM2D2 cells, the control transfectant H I I and the SO3 cell line, which had a low level of S I transcripts, a high incorporation of label in 40-41-kD proteins was observed. These 40-and 41-kD proteins probably represent Ga,? and Gai3 subunits, respectively. In contrast, in the S09 and S05 cells, labeling was only 5% and 12% of that in TAM2D2 cells, respectively. In the S04 transfectant, which expressed an intermediate level of S1 mRNA, this was 41%. These results indicated that the three latter transfectants express SI mono-ADPribosyltransferase activity. We also assayed whole cell lysates of these transfectants for ADP-ribosyltransferase activity towards TAM2D2 plasma membranes, but even after 24 hours of incubation, no incorporation of label in the Gaisubunits was observed.
To verify that the pcDNAhygSI construct did encode a functional S 1 mono-ADP-ribosyltransferase protein, it was 
+l-
The incorporation of 32P in G,-proteins in ADP-ribosylation experiments, a s described in Fig 2, was quantitated For Because we observed considerably reduced labeling of G-proteins in S 1 transfectants, whereas we detected neither S I protein nor ADP-ribosyltransferase activity in the lysates in vitro, we conclude that very low levels of SI protein are sufficient to ADP-ribosylate G, proteins.
To establish that the reduced labeling of Go,-subunits of SOS and S09 cell lines by exogenous FT was due to ADPribosylation by the endogenous (transfected) S I enzyme and not due to lower amounts of Goi-subunits in these clones, we determined Go, expression by Northern and Western blot analysis. Gat? and Goi3 mRNAs were detected, whereas Gm,, and Ga,,, the other FT-sensitive G-proteins, were not expressed (data not shown). As shown in Fig 4, Western blot analysis of plasma membranes showed similar amounts of and Goi2 in TAM2D2 and S09 and SOS cells. Note the slower migration in SDS-PAGE of Go,' and Gail subunits, in S09 and SOS cells, and in TAM2D2 cells that had been cultured in the presence of 200 ng/mL PT for 6 days. This slower migration is characteristic for ADP-ribosylated Gproteins'" and thus provides independent evidence that most of the Go,? and Ga,? proteins in S05 and S09 cells are ADPribosylated. A doublet band of Ga,' was observed. This may be due to phosphorylation of All cells expressed similar amounts of GP-and a,,-subunits.
Acllwsion tnolec~ule erpression ~n c l ~d l~e s i v e oncl invcrsive ccrpcrcity of the trr~ns~ctcrnts. The expression levels of adhesion molecules potentially relevant for metastasis were determined by flow cytometry. As mentioned before. the LFA-I integrin is required for metastasis of the TAM2D2 cells." CD44 has also been implicated in lymphoma metastasis," but for MDAY-D2 lymphoma cells we have shown that CD44 is not required for cells to metastasize to the liver and spleen." The a601 integrin may be involved in melanoma metastasis to the L-selectin expression on the cells was very low as had been determined previously.'" CD44 and LFA-I were present at high levels and the o6Pl integrin at low levels: the level of expression was not different on the transfectants compared with the parental cells (results not shown).
Of the 12 transfectants shown in Fig I , invasion of S05 and S09 cells into rat embryo fibroblast monolayers was low and comparable to that of PT-pretreated TAM2D2 cells (Table l) . Invasion by the S04 cells was reduced compared with that of parental TAM2D2 cells, but was higher than PT TAMTAM SO9 S05 B   Fig 4. G%-. G a r , Ga,-, and GP-subunits in S1 transfectants. Fifteen micrograms of membrane protein was subjected t o immunoblotting using G-protein antisera as described in the Materials and Methods. Samples were in this order: TAM2D2 cells cultured in the Presence Of 200 nglmL PT for 6 days; TAM2D2 cells; and SO9 and S05 cells. invasion by FT-pretreated TAM2D2 cells. Other transfectants (data not shown), including the H1 1 control cells, were highly invasive. Also, the three other transfectants that had been selected because of reduced invasiveness in the initial screening were highly invasive in subsequent tests. Of those 12 transfectants, only in S04, S05, and S09 plasma membranes was a substantial reduction in the amount of G-proteins ADP-ribosylated by exogenous PT detected. Thus, invasive capacity correlated with the amount of functional Gai-protein present in the cells.
Previously, it was established that inhibition of invasion of TAM2D2 cells by PT was reversed by Mn"," probably because Mn2+ stimulates adhesion mediated by LFA-1. In  Fig 5 , it is shown that both Mn2' and the phorbol ester PMA, another activator of LFA-l -mediated adhesion,'" stimulate adhesion to ICAM-1. TAM2D2 T-cell hybridoma cells and the S05 and S09 cells were allowed to adhere to wells coated with murine ICAM-1. Very few cells adhered without stimulation (Fig 5) . Mn2+ induced adhesion of approximately 35% of the cells at 2 mmoVL, at which concentration adhesion was maximal, in the absence of other divalent cations. Also -30% of cells treated with PMA (100 ng/mL in medium with 1 mmol/L Mg2+ and l mmol/L Caz+) adhered to ICAM-
1.
Invasion of S05 and S09 cells was low (only l%), but in the presence of 2 mmoVL Mn2' or 100 ng/mL PMA, both S05 and S09 cell lines did invade REF to a level similar to that of PT-pretreated TAM2D2 cells in the presence of Mn2' or PMA (Fig 6) . This finding further indicates that the lack of invasion is due to the ADP-ribosylation of Gi-proteins and not to clonal variation in other parameters that influence invasiveness.
DRIESSENS ET AL
Metastatic capacity of SI transfectants. In the first experiment, 5 X 10' cells were injected into a tail vein of syngeneic mice. Mice were autopsied when moribund or after 28 days, and the presence of metastases was determined both macroscopically and microscopically. The results of this experiment are shown in Table 2A . TAM2D2 cells formed metastases in the liver, spleen, kidneys, lymph nodes, and ovaries. The liver was either diffusely invaded or COIItained multiple nodules. In some cases, tumor was also found in the retroperitoneal fat and muscle tissue. In contrast, SO9 cells formed only in one of five animals metastases in the liver (only 1 nodule) and in the spleen, whereas metastases in the lymph nodes and in the retroperitoneal tissue were found in most of the mice. S05 cells metastasized to the same organs as TAM2D2 parental cells, but metastasis was reduced: two of five animals had considerable tumor growth in the liver, whereas three animals had only a few nodules. Spleen tumors occurred only in three of five animals. but at the other sites considerable metastasis was observed.
In a second experiment using a lower dose of tumor cells (lo'), we also tested the control transfectant HI I . Animals were killed when moribund or after 28 days. Liver and spleen weights were determined as a measure for the amount of tumor. The results are shown in Table 2B . A11 mice injected with TAM2D2 cells and almost all animals injected with the control transfectant H1 1 developed metastases in liver, spleen, and kidneys. Tumor burden in liver and spleen was similar in these two groups. In this experiment, with the lower cell dose, the tumor burden in SOS-injected mice was much lower (and now significantly different from TAM2D2-and H1 l-injected mice), but again the reduction in metastasis For was most evident in the animals injected with S09 cells (Fig  7) . Only 4 of the 12 mice had metastases, the other 8 were tumor-free after 28 days, when the experiment was terminated. The metastases in these 4 mice were mainly located in the lymph nodes and in retroperitoneal fat and muscles. Only 1 of the animals had a tumor nodule in the liver. Tumor cells were also present in the spleens of the 4 mice, but the amount of tumor (ie, spleen weight minus the weight of control spleens) was reduced: 54 mg as compared with 172 and 115 mg in the TAM2D2 and H1 1 groups, respectively (Fig 7B) . The S05 group had a tumor burden in the spleen of 58 mg. To determine whether metastases were formed by cells with similar S1 levels as the injected cells or perhaps by variants with reduced S1 expression, we isolated cells from randomly selected metastases of S05 and S09 cells. S1 mRNA expression in the metastases was similar as in the injected cell population, showing that S1 expression was stable during the in vivo experiment (data not shown).
Gi-PROTEINS INVOLVED IN T-CELL HYBRIDOMA METASTASIS
Occasionally, metastases occurred in the submandibular lymph nodes, which obstructed the esophagus. These animals could not eat, their body weight was reduced, and they died prematurely (19 days). The frequency was comparable in all groups: TAM2D2, 1 of 13; H11, 2 of 11; S05, 2 of 12; and S09, 1 of 13. These mice were excluded from the analysis.
To establish that all cell lines were able to grow in vivo, lo6 cells were injected intraperitoneally into six syngeneic AKR mice. On day 14, all animals had developed ascitic fluid. The total number of tumor cells present in the ascitic fluid was, on average, 23 X lo6 cells/mouse for TAM2D2, 3121 46 X lo6 for S05, 82 X lo6 for H11, and 155 X lo6 for S09 cells. We conclude that the reduced metastatic capacity of S05 and S09 cells cannot be attributed to impaired in vivo growth.
DISCUSSION
To assess the role of Gi-proteins in metastasis of T-cell hybridomas, we generated transfectants in which Gi-proteins are uncoupled from receptors by continuous expression of the ADP-ribosyltransferase S1 subunit of FT. We report here a substantial reduction in the metastatic capacity of two S1 transfectants, in which 88% or 95% of the Gi-proteins was ADP-ribosylated and thereby unable to transduce signals from the receptor. Two-thirds of the mice injected with the S09 tranfectant with the highest amount of ADP-ribosylated Gi-proteins were tumor-free. The reduction was particularly striking for the liver, which was tumor-free in virtually all mice, quite in contrast to the extensive tumor burden in control mice. Metastasis in spleen and kidneys was also strongly reduced. This reduction in metastatic capacity is much larger than that observed for PT-pretreated cells in previous experiments," in which liver metastasis was reduced but not prevented, and metastasis to kidneys, ovaries, and lymph nodes was seemingly not affected. Thus, permanent expression of S 1, rather than transient activity after FTpretreatment, greatly enhances its effect. The S05 transfectant with 88% ADP-ribosylated G-proteins metastasized to all sites, but tumor burden in the liver and spleen was much reduced when 100,000 tumor cells were injected. These results support the notion that functional Gi-proteins are re- For personal use only. on October 27, 2017. by guest www.bloodjournal.org From 3122 DRIESSENS ET AL quired for efficient metastasis formation of TAM2D2 T-cell hybridoma cells.
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The reduced invasiveness of the transfectants was not due to clonal variation in expression of adhesion molecules or another property required, because invasion was restored by stimulation of LFA-1 by Mn2+ or the phorbol ester PMA, similar to what occurs in PT-pretreated cells." Furthermore, reduced metastasis was not due to impaired proliferation, because transfectants and parental cells grew equally well, both in vitro and in vivo.
S05 cells formed more metastases than S09 cells and in all animals, whereas two-thirds of the mice in the S09 group was tumor-free. S05 cells contain approximately twofold more functional G,-proteins than S09 cells (12% v 5%). Therefore, the level of Gi -protein is apparently more critical in vivo than in short-term in vitro invasion assays, in which S05 and S09 cells performed equally poorly, and even the S04 cells, with 40% functional G,-proteins, showed reduced invasiveness. We assume that the capability of S05 cells to still form some metastases in the liver and spleen is due to the extended time period allowed for in vivo invasiveness. This may also explain the limited effect of PT-pretreatment: the cells may have invaded after several days when the effect of the toxin had dwindled.
PT causes lymphocytosis due to inhibition of lymphocyte migration from the blood into tissues or across lymph node endothelium.'.'' Furthermore, in transgenic mice expressing the S1 catalytic subunit under the control of a thymus-specific promoter, thymocytes develop normally, but the mature T cells do not leave the thymusi7 and, on transfer to other mice, are unable to leave the PT prevents the activation-dependent firm adhesion of lymphocytes to high endothelial venules, which is required for lymphocyte arrest and subsequent migration. 32 We propose that, in tumor cells in which G, -proteins are ADP-ribosylated, the transduction of the recruitment signal is impaired. Therefore, entry of tumor cells from the blood into tissues is prevented, leading to reduced metastasis formation.
Metastasis of the transfectants was not completely prevented in all mice, particularly not to spleen, kidneys, lymph nodes, and retroperitoneal tissue. Invasion at these sites may have been induced via other signal pathways. For example, tumor necrosis factor a can stimulate invasion of TAM2D2 cells by a PT-insensitive me~hanism.~' Furthermore, LFAl-independent mechanisms may play a role in metastasis to these sites, because LFA-1 -deficient mutants of TAM2D2 cells occasionally formed metastases in retroperitoneal tissue. ' G-proteins are heterotrimers that bind to cell surface receptors, in most cases proteins with seven transmembrane domains. The factors that activate adhesion, invasion, and metastasis of T-cell hybridoma cells are not known, but the most obvious candidates are members of the chemokine family. Macrophage chemotactic protein-l (MCP-l), MCP-2, MCP-3, macrophage inflammatory protein-la (MIP-l a ) , MIP-1P, and interferon-y-inducible protein have been described to be major chemoattractants for T lymphocyte^.^^"^ It is conceivable that some of these factors induce metastasis formation, even in the absence of inflammation, and observations supporting this notion have been reported. For instance, MCP-1 is expressed in human symptom-free arteries and veins in vivo'* and in human liver fat-storing cells,3' and the murine chemokine KC is constitutively present in liver and spleen.") Because the TAM2D2 T-cell hybridoma, similar to many other lymphomas, metastasizes extensively to these organs, this chemokine is an interesting candidate. Alternatively, the relevant factor may not be involved in inflammation, but may be an as yet unknown chemokine regulating the normal recirculation of leukocyte subsets. The concept that chemokines are involved in this, was recently shown; in mice lacking the IL-8B receptor, recirculation of neutrophils was im~aired.~' However, there are also other candidates that do not bind to seven transmembrane receptors, but instead to tyrosine kinase receptors, because certain signals induced by granulocyte-macrophage colony-stimulating factor (GM-CSF),4* epidermal growth factor,'" hepatocyte growth factor (HGF)?' and basic fibroblast growth factorJ5 have been shown to be sensitive to PT. In fact, HGF induces memory T-cell adhesion and migration. 44 Identification of the involved factors may suggest ways to interfere with metastasis using antagonists or inhibitors.
